MEDBX | MEDCX | MEDBX / MEDCX | |
Total Expense Ratio | 1.81 | 1.81 | 100% |
Annual Report Gross Expense Ratio | 1.82 | 1.82 | 100% |
Fund Existence | 23 years | 23 years | - |
Gain YTD | 2.365 | 2.366 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.11B | 7.11B | 100% |
Annual Yield % from dividends | 5.69 | 5.69 | 100% |
Returns for 1 year | 6.15 | 6.15 | 100% |
Returns for 3 years | 16.33 | 16.33 | 100% |
Returns for 5 years | 6.03 | 6.00 | 100% |
Returns for 10 years | 25.64 | 25.52 | 100% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSFCX | 20.55 | 0.34 | +1.68% |
Federated Hermes Clover Small Value C | |||
FGIQX | 15.67 | 0.21 | +1.36% |
Macquarie Growth and Income R6 | |||
FSYJX | 9.79 | 0.01 | +0.10% |
Fidelity Sustainable Emerging Markets Eq | |||
DISCX | 23.10 | N/A | N/A |
BNY Mellon International Stock Fund C | |||
GLDCX | 28.54 | -0.62 | -2.13% |
Gabelli Gold C |